Inventor · disambiguated record
Sanjay Srivastava
Also filed as: SRIVASTAVA SANJAY · SRIVASTAVA SANJAY K · SRIVASTAVA SANJAY KUMAR
14 granted patents·8 pending applications·27 citations·filing 2002–2025
87Inventor score
Files withTORRENT PHARMACEUTICALS LTD7UNIV TEXAS TECH SYSTEM6BANTAM PHARMACEUTICAL LLC3ASTRAZENECA AB2BROWN WILLIAM1
Top patents by PatentIndex Score
22 records- 0187US10463649B2Inhibitors of Mc1-1 as drugs to overcome resistance to BRAF inhibitors and MEK inhibitorsUNIV TEXAS TECH SYSTEM·Filed 2016·Granted Nov 5, 2019·11 cites·9 claims
- 0278US11602526B2Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating theretoBANTAM PHARMACEUTICAL LLC·Filed 2020·Granted Mar 14, 2023·1 cites·27 claims
- 0377US10537558B2Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating theretoBANTAM PHARMACEUTICAL LLC·Filed 2016·Granted Jan 21, 2020·3 cites·28 claims
- 0474US9908898B2Fused imidazobenzothiazole compoundsTORRENT PHARMACEUTICALS LTD·Filed 2015·Granted Mar 6, 2018·3 cites·9 claims
- 0574US7615642B2Therapeutic compoundsASTRAZENECA AB·Filed 2007·Granted Nov 10, 2009·3 cites·2 claims
- 0667US7501443B2Flavaxate derivatives as muscarinic receptor antagonistsRANBAXY LAB LTD·Filed 2002·Granted Mar 10, 2009·5 cites·4 claims
- 0757US8541430B2Fused thiazolo and oxazolo pyrimidinonesSRIVASTAVA SANJAY·Filed 2010·Granted Sep 24, 2013·1 cites·3 claims
- 0856US9610247B2Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel diseaseTORRENT PHARMACEUTICALS LTD·Filed 2014·Granted Apr 4, 2017·0 cites·12 claims
- 0954US2023302202A1Vitro bioprinted tumor models and bioinks for solid tumor bioprintingUNIV TEXAS TECH SYSTEM·Filed 2023·Application pending·0 cites
- 1053US2023038646A1Novel and potent jak/stat inhibitorUNIV TEXAS TECH SYSTEM·Filed 2021·Application pending·0 cites
- 1151US2025172541A1In vitro bioprinted bone models and bioinks for bone bioprintingUNIV TEXAS TECH SYSTEM·Filed 2025·Application pending·0 cites
- 1250US10471005B2Low dose pharmaceutical compositionTORRENT PHARMACEUTICALS LTD·Filed 2017·Granted Nov 12, 2019·0 cites·13 claims
- 1350US2022339145A1Compositions and Methods for Treating CancerUNIV TEXAS TECH SYSTEM·Filed 2022·Application pending·0 cites
- 1448US2011086853A1Therapeutic CompoundsBROWN WILLIAM·Filed 2009·Application pending·0 cites
- 1547US8822484B2Fused thiazolo and oxazolo pyrimidinonesTORRENT PHARMACEUTICALS LTD·Filed 2013·Granted Sep 2, 2014·0 cites·6 claims
- 1645US11357766B2Compositions and methods for treating cancerUNIV TEXAS TECH SYSTEM·Filed 2018·Granted Jun 14, 2022·0 cites·9 claims
- 1744US10227361B2Fused imidazobenzothiazole compoundsTORRENT PHARMACEUTICALS LTD·Filed 2018·Granted Mar 12, 2019·0 cites·13 claims
- 1843US2010305140A1Benzimidazole derivatives which are to be used as antagonist for the cb1-receptorASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1942US12150934B2Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseasesBANTAM PHARMACEUTICAL LLC·Filed 2017·Granted Nov 26, 2024·0 cites·31 claims
- 2034US2019127381A1Substituted fused pyrimidinone compoundsTORRENT PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 2131US2012046317A1Novel heterocyclic compoundsDUTT CHAITANYA·Filed 2010·Application pending·0 cites
- 2228US9963463B2Urea-substituted indanes as P38 map kinase inhibitorsTORRENT PHARMACEUTICALS LTD·Filed 2015·Granted May 8, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Sanjay Srivastava files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →